Transcutaneous Oxygen and Nasal High Flow in healthy adults

Not Applicable

Recruiting

• Conditions: Anaesthesia; Anaesthesiology - Other anaesthesiology; Respiratory - Normal development and function of the respiratory system

• Registration Number: ACTRN12622001278729
• Lead Sponsor: Fisher & Paykel Healthcare

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-09-29
• Last Update Posted: 12 December 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

1. Willing and able to provide written informed consent
2. 18 to 40 years of age, inclusive

Exclusion Criteria

1. Participants where continuous positive airway pressure and nasal high flow are contraindicated (e.g. nasal congestion, currently has or has history of epistaxis, pneumothorax, bullous lung disease, craniofacial trauma, airway foreign body).
2. Known active use of tobacco, vapes, or other inhaled substances.
3. BMI > 35 kg/m2
4. Known fragile skin and/or adhesive allergy
5. Other underlying medical condition that will be unfavourable for the administration of nasal high flow therapy or may impair compliance with study conduct.

Study & Design

• Study Type: Interventional
• Study Design: Not specified